Cite
HARVARD Citation
Tanriover, M. et al. (2021). Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 398 (10296), pp. 213-222. [Online].